看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
8 J4 Q" ?7 H+ z/ o; p: t5 k
1 ?1 D1 H! o6 S- N( [. B4 T6 B J0 o$ d- V# {
Currently available feasibility data for possible combination strategies. 1 Q# k: D6 u# P, u
————————————————————————————————
# c9 L0 c1 b7 x' r; V4 SCombination Feasibility according to preliminary data - x6 z* e: V l: m7 g/ I0 E l+ g- g
——————————————————————————————————6 B# v+ L4 p" S0 `( ?: o0 d* o
Bevacizumab + sorafenib Yes, reduced dose 7 L2 j7 i4 L- i; l& X5 Q
Bevacizumab + sunitinib† No ( X Z9 W( w2 R* Z) L
Bevacizumab + temsirolimus Yes
; [; h/ }+ x5 F9 u5 bBevacizumab + everolimus Yes 9 N- i5 [. Q9 T* `# @! S
Sorafenib + sunitinib ?
' }4 l, b' z4 h) c2 h# CSorafenib + temsirolimus Yes, reduced dose . D9 P7 ]% h- g# }3 J
Sorafenib + everolimus Yes, reduced dose 7 I! U1 Y/ W v6 G5 {. ]. i' W
Sunitinib + temsirolimus† No 6 H. o1 i4 Y( h" V8 c. T3 y$ y/ j
Sunitinib + everolimus ?
1 t' T& |5 T, G6 D6 YTemsirolimus + everolimus ? 8 w0 F4 R3 H# ]1 \1 c3 _1 G
————————————————————
% j& M: c$ k- r†Led to US FDA warning.
: _7 V1 Y( R2 R8 }; {8 _. a8 q?: As yet unattempted combination.7 W+ J4 I4 c: N: G6 _3 {
|